Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1Phase 2 1

Status

Unknown 125Completed 101Recruiting 36Not yet recruiting 25Terminated 16Active not recruiting 11Withdrawn 7Suspended 4Enrolling by invitation 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 1Colorectal Neoplasms 1

Interventions

Specimen Handling 34Magnetic Resonance Spectroscopy 22Biopsy 20Cyclophosphamide 16Nivolumab 10Paclitaxel 9Cisplatin 9Gemcitabine 8Bevacizumab 8venetoclax 7Vincristine 7Prednisone 7Doxorubicin 7Azacitidine 7pembrolizumab 6Radiotherapy 6Radiosurgery 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Taxes 5Surgical Procedures, Operative 5Rituximab 5Oxaliplatin 5Irinotecan 5Everolimus 5Capecitabine 5fludarabine phosphate 4fludarabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Suspended × S 1 (combination) × Clear all
NCT00209729 2010-05-26

Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.

Hokkaido Gastrointestinal Cancer Study Group

Phase 1/2 Suspended
50 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00209677 2007-11-01

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 1/2 Suspended
40 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00316745 2007-11-01

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 3 Suspended
200 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00209664 2006-02-02

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 2 Suspended
40 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡